Trials / Completed
CompletedNCT03264690
Study to Observe the Change in Microbiome in Human Derived Sample and the Relation With Clinical Response Before and After the Anti-TNF Treatment in IBD Patients
A Prospective Study to Observe the Change in Microbiome in Human Derived Sample and the Relation With Clinical Response Before and After the Anti-TNF Treatment in IBD Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Eisai Korea Inc. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
This study will be conducted to observe the difference in microbiome composition between healthy participants and inflammatory bowel disease (IBD) participants with no anti-tumor necrosis factor (anti-TNF) treatment.
Conditions
Timeline
- Start date
- 2017-09-21
- Primary completion
- 2020-01-16
- Completion
- 2020-01-16
- First posted
- 2017-08-29
- Last updated
- 2020-03-10
Locations
3 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03264690. Inclusion in this directory is not an endorsement.